The market reacted positively, up 8.4%, reflecting TransUnion’s earnings and raised full-year guidance that beat expectations on organic revenue growth and adjusted diluted EPS, driven by broad-based strength across segments and continued innovation momentum.
Shares of TransUnion fell 1.0% following earnings as first quarter results and updated 2026 guidance appeared broadly in-line with investor expectations. Management maintained a cautious approach to full-year guidance, balancing Q1 outperformance against ongoing macro uncertainty.
TransUnion delivered strong Q3 2025 results, marking the seventh consecutive quarter of high single-digit organic revenue growth, driven by robust market performance and strategic advancements.
TransUnion demonstrated robust performance in Q2 2025, exceeding key financial guidance with a 9% organic revenue growth and solid gains across multiple segments.